---
title: "Evolv Tech Holdings - CW25 | 8-K: FY2025 Q1 Revenue: USD 32.01 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241180155.md"
datetime: "2025-05-21T08:17:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241180155.md)
  - [en](https://longbridge.com/en/news/241180155.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241180155.md)
generator: "portal-rs"
---

# Evolv Tech Holdings - CW25 | 8-K: FY2025 Q1 Revenue: USD 32.01 M

Revenue: As of FY2025 Q1, the actual value is USD 32.01 M.

EPS: As of FY2025 Q1, the actual value is USD -0.01.

### Segment Revenue

-   **Total Revenue**: $32.0 million in Q1’25, up 44% YoY from $22.2 million in Q1’24.
-   **Recurring Revenue**: $25.8 million in Q1’25, up 36% YoY from $19.0 million in Q1’24.
-   **Non-recurring Revenue**: $6.3 million in Q1’25, up 94% YoY from $3.2 million in Q1’24.

### Operational Metrics

-   **Net Loss**: - $1.7 million in Q1’25, improved from - $11.3 million in Q1’24.
-   **Net Profit Margin**: -5% in Q1’25, improved from -51% in Q1’24.
-   **Adjusted EBITDA**: $1.7 million in Q1’25, compared to - $10.4 million in Q1’24.

### Cash Flow

-   **Net Cash Used in Operating Activities**: - $2.5 million in Q1’25, improved from - $16.2 million in Q1’24.

### Unique Metrics

-   **Annual Recurring Revenue (ARR)**: $106.0 million at the end of Q1’25, up 34% YoY from $79.2 million at the end of Q1’24.

### Outlook / Guidance

-   The company expects total revenues in 2025 to be between $125 to $130 million, reflecting growth of 20% to 25% compared to 2024.
-   Evolv Technology plans to make near-term investments of approximately $2 million in 2025 to enhance internal controls and drive efficiencies.
-   The company anticipates delivering positive full year Adjusted EBITDA in 2025 with margins in the low to mid-single digits and positive free cash flow in Q4’25.

### Related Stocks

- [EVLVW.US](https://longbridge.com/en/quote/EVLVW.US.md)

## Related News & Research

- [Is Camtek (CAMT) Options Frenzy Quietly Reframing Its Near‑Term Earnings Story?](https://longbridge.com/en/news/298114664.md)
- [The Bull Case For Natera (NTRA) Could Change Following New Signatera Lymphoma Data And Komen Partnership](https://longbridge.com/en/news/298111249.md)
- [Stronger Q2 Results And Raised 2026 Outlook Could Be A Game Changer For IDEXX Laboratories (IDXX)](https://longbridge.com/en/news/298111178.md)
- [NBH Bank Makes New Investment in Bank of America Corporation $BAC](https://longbridge.com/en/news/298108822.md)
- [MW Advisory LLC Makes New $1.77 Million Investment in Visa Inc. $V](https://longbridge.com/en/news/298108585.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**